Quick answer
Inhibrx Biosciences, Inc. (INBX) last filed its quarterly results with the SEC on 2026-08-13 (Form 8-K, Item 2.02); SEC records 9 earnings filings for it; the latest 9 are listed below. The next date is set by the company and is not in SEC data until it files.
Earnings release filings (8-K Item 2.02)
| Filed | Filing |
|---|---|
| 2026-08-13 | 8-K |
| 2026-05-14 | 8-K |
| 2026-03-19 | 8-K |
| 2025-11-14 | 8-K |
| 2025-08-13 | 8-K |
| 2025-05-14 | 8-K |
| 2025-03-17 | 8-K |
| 2024-11-14 | 8-K |
| 2024-08-13 | 8-K |
Updated 2026-08-13. Source: SEC EDGAR filings (linked above). Data only. Not investment advice, no buy/sell recommendation.
Related answers
- Who is buying INBX stock? Insider buyers of Inhibrx Biosciences, Inc.
- INBX insider buying this week: $1.70M in open-market buys